FDA Issues Emergency Use Of Convalescent Plasma For COVID–19 Treatment

FDA Issues Emergency Use Of Convalescent Plasma For COVID–19 Treatment

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the agencys…
Read More